Revisions to USP General Chapter may impact evaluation of sterile product package integrity. A proposed revision of the United States Pharmacopeia (USP) General Chapter <1207>, Sterile Product Package ...
At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...
Changes in CCIT testing have followed the evolution of regulatory guidance, and this article examines different possible CCIT strategy approaches. Container closure integrity (CCI) plays an important ...
False positives can occur when performing sterile integrity testing. Understanding how to identify them can help minimize their occurrence in future package designs. By Curtis L. Larsen Some medical ...
PTI introduces the next generation VeriPac Inspection System, the VeriPac 310. This new model replaces the popular first generation VeriPac 225 and 325 test systems. The new VeriPac 310 is ideal for ...
(MENAFN- ForPressRelease) STEMart, a US-based provider of comprehensive services for all phases of medical device development, proudly announces the launch of its new Sterile Barrier & Seal Integrity ...
A medical device's package plays a key role in safely delivering treatment to patients. It must ensure the integrity of the device from the point of manufacture to the point of final use. In addition, ...
Purple Diamond’s packaging engineers ensure safe and reliable consumer goods and pharmaceutical packaging for global distribution. These critical tests, developed by the International Safe Transit ...
(MENAFN- GetNews) STEMart launches new Sterile Barrier & Seal Integrity Testing services to optimize medical device packaging. STEMart, a US-based provider of comprehensive services for all phases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback